Proxygen
PrivateLast Round
Strategic
Apr 5, 2023
Total Funding Raised
$250,000
Company Overview
Proxygen operates in Healthcare & Life Sciences and is based in Vienna. Its latest recorded funding round was a Strategic round in April 2023.
Proxygen is a biotechnology company developing a new class of therapeutics based on induced proximity to address high-value targets in oncology and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proxygen Comparables
Compare Proxygen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neomorph | 89% | |
| Degron Therapeutics | 88% | |
| Plexium | 88% |
For institutional investors. Book with your work email.
Proxygen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Apr 5, 2023 | ||||
| Strategic | Jun 2, 2022 | ||||
| Strategic | Dec 7, 2020 | ||||
| Grant | Jul 31, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Proxygen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boehringer Ingelheim | Grant, Strategic |
| Wlanholding | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors grew 49% MoM.
- Aug 8, 2023
Grew 30% QoQ, from 23 to 30 employees.
For institutional investors. Book with your work email.
Proxygen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Proxygen's valuation, stock price, and market status.
Is Proxygen a public or private company?
Proxygen is a private company.
What is the current stock price of Proxygen?
Proxygen is a private company, so its shares have no public market price. Caplight tracks Proxygen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Proxygen worth (valuation)?
Valuation information for Proxygen is not publicly available.
Can I buy Proxygen stock?
Proxygen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Proxygen's last funding round?
Proxygen's most recent funding round was Strategic on April 5, 2023.
Who are the main investors in Proxygen?
Key investors in Proxygen include Boehringer Ingelheim, Wlanholding.
Will Proxygen IPO soon?
No public IPO plans have been announced for Proxygen.
How can I track Proxygen secondary market activity?
Caplight tracks bids, offers, and trades in Proxygen's shares on secondary markets.